← Evidence map

ArticleAnnals of medicine and surgery (2012)2025

Mirikizumab: a landmark in IL-23-targeted therapy for ulcerative colitis.

Muhammad Usman Iqbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41377387